Research
Inventory.
Access our verified catalog of high-purity research compounds. Each unit is individually gated by rigorous analytical standards.
Search Results: 31 Compounds Found
Buffered NAD+
Beta-Nicotinamide Adenine Dinucleotide for cellular research
SS-31
Mitochondria-targeted tetrapeptide for cardiolipin and mitochondrial membrane research.
ADAMAX
Investigational Semax-related peptide analog for comparative stability and peptide chemistry research.
CJC-1295 + IPAMORELIN BLEND
Dual-peptide blend for comparative GHRH and ghrelin-receptor signaling research.
PT-141
PT-141 (Bremelanotide) | Research Use Only Synthetic Cyclic Heptapeptide | ≥98% Purity | Lyophilized Powder CAS: 189691-06-3 Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, featuring a lactam bridge between the aspartic acid and lysine residues Molecular Formula: C₅₀H₆₈N₁₄O₁₀ Molecular Weight: 1025.2 g/mol Also known as: Bremelanotide, Vyleesi (FDA-approved brand), MTP-II metabolite For Research Use Only. Not intended for human or veterinary use. PT-141 is a synthetic analogue of α-melanocyte-stimulating hormone (α-MSH) used in laboratory research to study melanocortin receptor pathways. It is a cyclic heptapeptide cyclized via a lactam bridge between Asp and Lys residues. This cyclic structure confers significantly greater metabolic stability compared to linear α-MSH analogs. Bremelanotide acts as a non-selective agonist of the melanocortin receptors, primarily MC3R and MC4R, present in the central nervous system. These receptor subtypes are most highly expressed in the hypothalamus and limbic system.
AOD 9604
AOD 9604 is a synthetic peptide fragment originally derived from growth hormone research. It was designed as a modified version of the C-terminal portion of human growth hormone (hGH). Researchers have explored its potential relationship to lipid metabolism and adipose tissue breakdown.
CJC-1295 (No DAC)
Short-acting GHRH analog for pulsatile growth hormone signaling research. 5mg per vial.
